Your browser doesn't support javascript.
loading
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
Maura, Francesco; Ziccheddu, Bachisio; Xiang, Jenny Z; Bhinder, Bhavneet; Rosiene, Joel; Abascal, Federico; Maclachlan, Kylee H; Eng, Kenneth Wha; Uppal, Manik; He, Feng; Zhang, Wei; Gao, Qi; Yellapantula, Venkata D; Trujillo-Alonso, Vicenta; Park, Sunita I; Oberley, Matthew J; Ruckdeschel, Elizabeth; Lim, Megan S; Wertheim, Gerald B; Barth, Matthew J; Horton, Terzah M; Derkach, Andriy; Kovach, Alexandra E; Forlenza, Christopher J; Zhang, Yanming; Landgren, Ola; Moskowitz, Craig H; Cesarman, Ethel; Imielinski, Marcin; Elemento, Olivier; Roshal, Mikhail; Giulino-Roth, Lisa.
Afiliación
  • Maura F; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
  • Ziccheddu B; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
  • Xiang JZ; Weill Cornell Medical College, New York, New York.
  • Bhinder B; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
  • Rosiene J; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
  • Abascal F; Weill Cornell Medical College, New York, New York.
  • Maclachlan KH; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, United Kingdom.
  • Eng KW; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Uppal M; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
  • He F; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
  • Zhang W; Weill Cornell Medical College, New York, New York.
  • Gao Q; Weill Cornell Medical College, New York, New York.
  • Yellapantula VD; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Trujillo-Alonso V; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Park SI; Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles, Los Angeles, California.
  • Oberley MJ; Weill Cornell Medical College, New York, New York.
  • Ruckdeschel E; Department of Pathology, Children's Hospital of Atlanta, Atlanta, Georgia.
  • Lim MS; Caris Life Sciences, Phoenix, Arizona.
  • Wertheim GB; Department of Pathology, Upstate Medical University, Syracuse, New York.
  • Barth MJ; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia.
  • Horton TM; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia.
  • Derkach A; Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Kovach AE; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Forlenza CJ; Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhang Y; Children's Hospital of Los Angeles, Los Angeles, California.
  • Landgren O; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Moskowitz CH; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cesarman E; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
  • Imielinski M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
  • Elemento O; Weill Cornell Medical College, New York, New York.
  • Roshal M; Weill Cornell Medical College, New York, New York.
  • Giulino-Roth L; Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
Blood Cancer Discov ; 4(3): 208-227, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36723991
ABSTRACT
The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13, and PTPN1, and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis.

SIGNIFICANCE:

Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Células de Reed-Sternberg Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Células de Reed-Sternberg Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article